Lynda Baron
Nurse Practitioner · Eatontown, NJNPI 1851454862
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.7%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Progenics Pharmaceuticals, Inc. at 39.3% of the total. Reporting peaked in 2021 at $2,866 and has fallen 81.9% since, to $520 in 2025. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 199 payments — averaging $32.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Progenics Pharmaceuticals, Inc.$3K
- Astellas Pharma US Inc$514
- Abbott$452
- Johnson & Johnson$320
- Dendreon Pharmaceuticals LLC$304
- 180 Medical, Inc.$279
- plus $2K from 24 others
What the payments were for
- Consulting fees$1,00015%
- Speaking & faculty fees$1,50023%
- Food & beverage$3,66757%
- Education$2995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Progenics Pharmaceuticals, Inc. | 5 | $2,544 |
| Astellas Pharma US Inc | 23 | $514 |
| Abbott | 17 | $452 |
| Johnson & Johnson | 16 | $320 |
| Dendreon Pharmaceuticals LLC | 14 | $304 |
| 180 Medical, Inc. | 11 | $279 |
| Sumitomo Pharma America, Inc. | 15 | $250 |
| Antares Pharma, Inc. | 13 | $239 |
| Myriad Genetic Laboratories, Inc. | 9 | $218 |
| Urogen Pharma, Inc. | 13 | $207 |
| AbbVie | 11 | $179 |
| Dentsply IH AB | 4 | $131 |
| Immunitybio, Inc. | 7 | $123 |
| Medtronic | 5 | $101 |
| Myovant Sciences Inc. | 7 | $99 |
| Urovant Sciences Inc | 5 | $73 |
| Halozyme Inc | 4 | $68 |
| Endo Pharmaceuticals Inc. | 3 | $48 |
| ABC Home Medical Supply, Inc. | 2 | $46 |
| Civco Medical Instruments | 1 | $35 |
| Axonics, Inc. | 2 | $34 |
| Bayer | 2 | $31 |
| Sun Pharmaceutical Industries Inc. | 2 | $31 |
| Hollister Incorporated | 2 | $30 |
| Laborie Medical Technologies Corp. | 1 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Accord Healthcare, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Merck | 1 | $15 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PYLARIFY$1,500
How this compares
$6,465 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 31 | $25,391 |
| MyrbetriqMirabegron | 15 | $11,554 |
| Tamsulosin Hcl | 160 | $3,065 |
| Silodosin | 22 | $2,557 |
| Estradiol | 18 | $2,240 |
| Oxybutynin Chloride ErOxybutynin Chloride | 37 | $1,246 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 64 | $1,001 |
| CefuroximeCefuroxime Axetil | 124 | $977 |
| Finasteride | 43 | $661 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $499 |
| Levofloxacin | 109 | $377 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $364 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $214 |
| Amoxicillin | 72 | $172 |
| Fluconazole | 18 | $145 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $250 | $25,39131 claims |
| Astellas Pharma US IncMyrbetriq | $514 | $11,55415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Eatontown
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.